DAFNA Capital Management LLC - FATE THERAPEUTICS INC ownership

FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 251 filers reported holding FATE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.41 and the average weighting 0.4%.

Quarter-by-quarter ownership
DAFNA Capital Management LLC ownership history of FATE THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$5,558,985
-54.1%
550,940
+2.0%
1.57%
-51.9%
Q3 2022$12,100,000
-11.4%
539,940
-2.0%
3.25%
-12.6%
Q2 2022$13,652,000
-29.7%
550,940
+10.0%
3.72%
-26.5%
Q1 2022$19,421,000
-10.8%
500,930
+34.6%
5.06%
-7.6%
Q4 2021$21,775,000
+6.7%
372,160
+8.1%
5.48%
+1.1%
Q3 2021$20,410,000
-25.2%
344,360
+9.5%
5.42%
-5.1%
Q2 2021$27,283,000
+5.3%
314,3600.0%5.71%
-7.2%
Q1 2021$25,919,000
-14.7%
314,360
-6.0%
6.15%
-32.0%
Q4 2020$30,403,000
+73.5%
334,360
-23.7%
9.05%
+58.8%
Q3 2020$17,525,000
+4.1%
438,460
-10.7%
5.70%
+17.2%
Q2 2020$16,841,000
+61.3%
490,861
+4.4%
4.86%
+11.6%
Q1 2020$10,439,000
+13.5%
470,0000.0%4.36%
+38.0%
Q4 2019$9,198,000
+26.0%
470,0000.0%3.16%
+15.0%
Q3 2019$7,299,000
+498.8%
470,000
+682.9%
2.74%
+499.3%
Q2 2019$1,219,000
+1131.3%
60,031
+197.3%
0.46%
+502.6%
Q1 2015$99,000
-66.7%
20,190
-65.8%
0.08%
-67.7%
Q4 2014$297,000
-23.3%
59,110
-22.2%
0.24%
-39.7%
Q3 2014$387,000
-19.2%
75,9300.0%0.39%
-14.1%
Q2 2014$479,00075,9300.45%
Other shareholders
FATE THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 3,379,064$7,163,6162.64%
Redmile Group, LLC 13,124,427$27,823,7851.32%
Monaco Asset Management SAM 1,847,944$3,917,6411.16%
Casdin Capital, LLC 2,050,000$4,346,0000.48%
TANG CAPITAL MANAGEMENT LLC 700,000$1,484,0000.21%
GCM Grosvenor Holdings, LLC 495,916$1,051,3420.21%
Nebula Research & Development LLC 163,617$346,8680.18%
Bellevue Group AG 4,851,579$10,285,3470.17%
Bruce & Co., Inc. 200,000$424,0000.14%
XTX Topco Ltd 192,920$408,9900.07%
View complete list of FATE THERAPEUTICS INC shareholders